Cargando…

Protective Effect of Huoxiang Zhengqi Oral Liquid on Intestinal Mucosal Mechanical Barrier of Rats with Postinfectious Irritable Bowel Syndrome Induced by Acetic Acid

In this study, a rat model with acetic acid-induced PI-IBS was used to study the role of HXZQ oral liquid in repairing the colonic epithelial barrier and reducing intestinal permeability. Pathomorphism of colonic tissue, epithelial ultrastructure, DAO activity in serum, and the protein expression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yao, Liu, Wei, Peng, Qiu-Xian, Peng, Jiang-Li, Yu, Lin-Zhong, Hu, Jian-Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164314/ https://www.ncbi.nlm.nih.gov/pubmed/25254052 http://dx.doi.org/10.1155/2014/218383

Ejemplares similares

Chinese Herbal Formula Huoxiang Zhengqi for Dampness Pattern in Atopic Dermatitis and Diarrhea-Predominant Irritable Bowel Syndrome: Rationale and Design of a Master Protocol
por: Huang, Qian, et al.
Publicado: (2021)

The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial
por: Guo, Xiaohui, et al.
Publicado: (2021)

The Chinese Herbal Formula Huoxiang Zhengqi Dropping Pills Prevents Acute Intestinal Injury Induced by Heatstroke by Increasing the Expression of Claudin-3 in Rats
por: Li, Yu-Nong, et al.
Publicado: (2022)

Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial
por: Xiao, Mingzhong, et al.
Publicado: (2020)

Modulatory Effects of Huoxiang Zhengqi Oral Liquid on Gut Microbiome Homeostasis Based on Healthy Adults and Antibiotic-Induced Gut Microbial Dysbiosis Mice Model
por: Gao, Min, et al.
Publicado: (2022)

The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats
por: Ma, Xiangxue, et al.
Publicado: (2017)

Effect of Huoxiang Zhengqi Pill on Early Neurological Deterioration in Patients with Acute Ischemic Stroke Undergoing Recanalization Therapy and Predictive Effect of Essen Score
por: Huang, Zhi-Xin, et al.
Publicado: (2020)

Huoxiang Zhengqi alleviates azoxymethane/dextran sulfate sodium-induced colitis-associated cancer by regulating Nrf2/NF-κB/NLRP3 signaling
por: Dong, Mingyuan, et al.
Publicado: (2022)

Therapy of the postinfectious irritable bowel syndrome: an update
por: IACOB, TEODORA, et al.
Publicado: (2017)

Huoxiang Zhengqi Oral Liquid Attenuates LPS-Induced Acute Lung Injury by Modulating Short-Chain Fatty Acid Levels and TLR4/NF-κB p65 Pathway
por: Tang, Ruying, et al.
Publicado: (2023)

The Chinese herbal formula Huoxiang Zhengqi for atopic dermatitis with dampness pattern (CHARM): a study protocol for a double-blinded randomized controlled trial
por: Xuan, Meiling, et al.
Publicado: (2021)

Exploring the synergistic pharmacological mechanism of Huoxiang Drink against irritable bowel syndrome by integrated data mining and network pharmacology
por: Wang, Ruo-Hui, et al.
Publicado: (2023)

Paeoniflorin Ameliorates Colonic Fibrosis in Rats with Postinfectious Irritable Bowel Syndrome by Inhibiting the Leptin/LepRb Pathway
por: Tian, Ya-Qing, et al.
Publicado: (2022)

Long-term Prognosis of Postinfectious Irritable Bowel Syndrome (Gut 2010;59:605-611)
por: Park, Jae Myung
Publicado: (2010)

Alteration of Fecal Microbiota in Patients With Postinfectious Irritable Bowel Syndrome: (Gut 2014;63:1737–1745)
por: Joo, Young-Eun
Publicado: (2015)

Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome
por: Liu, De-Rong, et al.
Publicado: (2018)

Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome
por: Omarova, Sholpan, et al.
Publicado: (2023)

Electroacupuncture Relieves Visceral Hypersensitivity by Inactivating Protease-Activated Receptor 2 in a Rat Model of Postinfectious Irritable Bowel Syndrome
por: Xu, Wanli, et al.
Publicado: (2018)

Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
por: Carroll, Ian M, et al.
Publicado: (2010)

Increased Immunoendocrine Cells in Intestinal Mucosa of Postinfectious Irritable Bowel Syndrome Patients 3 Years after Acute Shigella Infection - An Observation in a Small Case Control Study
por: Kim, Hee Sun, et al.
Publicado: (2010)

Cellular and Molecular Basis of Intestinal Barrier Dysfunction in the Irritable Bowel Syndrome
por: Martínez, Cristina, et al.
Publicado: (2012)

Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review
por: Hanning, Nikita, et al.
Publicado: (2021)

Effects of Intestinal Flora on Irritable Bowel Syndrome and Therapeutic Significance of Polysaccharides
por: Ye, Yang, et al.
Publicado: (2022)

Mucosal Mast Cell Count Is Associated With Intestinal Permeability in Patients With Diarrhea Predominant Irritable Bowel Syndrome
por: Lee, Hyuk, et al.
Publicado: (2013)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Clinical analysis of adenovirus postinfectious bronchiolitis obliterans and nonadenovirus postinfectious bronchiolitis obliterans in children
por: Huang, Fei, et al.
Publicado: (2021)

Correlation between Intestinal Microflora in Irritable Bowel Syndrome and Severity
por: Ji, Min, et al.
Publicado: (2022)

Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome
por: Yang, Jingze, et al.
Publicado: (2021)

Postinfectious Hemolytic Uremic Syndrome
por: Bitzan, Martin, et al.
Publicado: (2016)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Mechanism of Jiawei Zhengqi Powder in the Treatment of Ulcerative Colitis Based on Network Pharmacology and Molecular Docking
por: Zhao, Chao, et al.
Publicado: (2023)

The Intestinal Barrier in Irritable Bowel Syndrome: Subtype-Specific Effects of the Systemic Compartment in an In Vitro Model
por: Ludidi, Samefko, et al.
Publicado: (2015)

Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity
por: Prospero, Laura, et al.
Publicado: (2021)

Mucosal Microbiome Profiles Polygenic Irritable Bowel Syndrome in Mestizo Individuals
por: Arredondo-Hernández, Rene, et al.
Publicado: (2020)

Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis
por: Baumgartner, Maximilian, et al.
Publicado: (2021)

Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome
por: Salvo-Romero, Eloísa, et al.
Publicado: (2020)

Intestinal Mucosal Barrier Is Regulated by Intestinal Tract Neuro-Immune Interplay
por: You, Xin-yu, et al.
Publicado: (2021)

Postinfectious glomerulonephritis: Is there a role for steroids?
por: Kapadia, A. S., et al.
Publicado: (2011)

Prolonged Duodenal Mucosal Lymphocyte Alterations in Patients With and Without Postinfectious Functional Gastrointestinal Disorders After Giardia Infection
por: Dizdar, Vernesa, et al.
Publicado: (2019)

Aquaporin Expression in Colonic Mucosal Biopsies From Irritable Bowel Syndrome With Diarrhea
por: Camilleri, Michael, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t6jjb7tek5dh0ugf7jta8gg9ld